| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |